| Literature DB >> 24148020 |
Asbjorn Jokstad1, Hassan Alkumru.
Abstract
OBJECTIVES: To appraise the feasibility of loading four implants with a pre-existing denture converted to a fixed dental prosthesis (FDP) on the day of implant surgery compared with waiting for 3- to 4-month healing.Entities:
Keywords: alveolar bone loss; cantilever units; dental implants; fixed prosthesis; marginal bone level; radiographic evaluation; randomized clinical trial
Mesh:
Substances:
Year: 2013 PMID: 24148020 PMCID: PMC4278559 DOI: 10.1111/clr.12279
Source DB: PubMed Journal: Clin Oral Implants Res ISSN: 0905-7161 Impact factor: 5.977
Figure 1Progress plan of the trial over the 5 years.
Inclusion and exclusion criteria used in the current trial
| Inclusion criteria | Exclusion criteria |
|---|---|
|
Patient at least 18 years or older Edentulous mandible at least 3 months before date of implant surgery Eventual previous GBR/GTR procedures carried out at least 6 months prior to implant surgery Adequate oral hygiene Good dexterity for oral hygiene maintenance Absence of local inflammation, mucosal disease Adequate bone quality and quantity for placement of four implants between the two mental foramina without need for bone augmentation simultaneous with implant placement Commitment to follow-up examinations | Conditions requiring prolonged steroid use Presence of conditions requiring prophylactic use of antibiotics History of leukocyte dysfunction or deficiency, bleeding disorders, neoplastic disease, renal failure, uncontrolled endocrine disorders Use of any investigational drug or device within 30-day period immediately prior to implant surgery History of radiation therapy History of alcohol or drug abuse Patient infected with HIV Smoking >10 cigarettes per day or tobacco equivalent Visible indications of severe bruxism Advanced age and/or compromised general health so the surgical appointments are too demanding |
Need for site augmentation through grafting |
Figure 2Illustrative details of the conversion from a pre-existing conventional denture to a 10-unit fixed dental prosthesis in the experimental study arm.
Figure 3Illustrative details of the fabrication of the permanent full-arch metal-reinforced acrylic fixed dental prosthesis.
Figure 4Details of radiographic bone measurement points using a Brånemark System Implant with a regular platform (ø = 3.75 mm). Vertical bars from top of shoulder to horizontal part of the shoulder = 0.8 mm; First thread = 1.8 mm; Second thread = 2.4 mm; Third thread = 3.0 mm etc. The interthread distances = 0.6 mm. Other dimensions apply for the narrow and wide platform implants.
Figure 5Implants placed in the trial according to bone quality (1–4) and mandible shapes (Tapered – Parallel – Undercut – Knife-edge; n = 168 implants).
Figure 6CONSORT Flow diagram of study participants through the trial.
Baseline data of the participants that completed the 5-year follow-up examinations (n = 35/42 participants)
| Control group (ITT = PP; | Experimental group (PP; | Originally allocated to experimental group, but intended intervention not received ( | |
|---|---|---|---|
| Gender males, | 9 (50) | 9 (69) | 2 (50) |
| Age at implant placement, years, Mean (SD) (min–max) | 62 (9) (47–78) | 62 (11) (42–82) | 71 (3) (69–74) |
| Years edentulous, years, Mean (SD) (min–max) | 8 (12) (1–43) | 10 (13) (1–35) | 1 (0.3) (0.5–1) |
| Smoking, Current or former, | 11 (61) | 6 (46) | 3 (75) |
| Dental status in maxilla, Dentate–Full Denture–Partial Removable–Implant-retained prosth. | 1-13-3-1 | 0-9-3-1 | 0-4-0-0 |
| Bone quality (I–IV), | 18-36-18-0 | 0-16-36-0 | 8-8-0-0 |
| Bone form knife (K)–parallel (P)–taper (T)–undercut (U), | 36-10-22-4 | 20-20-12-0 | 8-0-0-8 |
| Implant diameter (3.3–3.75–4 mm), | 0-64-8 | 1-45-6 | 0-15-1 |
| Implant length (10–11.5–13–15 mm), | 1-4-5-62 | 5-9-38 | 6-3-7 |
Figure 7Crestal bone loss measured radiographically from baseline to 5 years following the implant placement (P > 0.05).
Radiographic bone loss measured at the 5-year follow-up examination (n = 35/42 participants, 140 implants, 280 mesial and distal measurement sites)
| Control group (ITT = PP; | Experimental group (PP; | Originally allocated to experimental group, but intended intervention not received ( | |
|---|---|---|---|
| Bone loss, | |||
| <1 mm | 57 (40) | 33 (32) | 12 (38) |
| 1 to <2 mm | 67 (49) | 48 (46) | 14 (44) |
| 2 to <3 mm | 15 (10) | 23 (22) | 6 (19) |
| >3 mm | 3 + 2 | 0 | 0 |
| Mean bone loss (SD) (max–min) | 1.1 (0.7) (0–3.3) | 1.3 (0.7) (0–2.9) | 1.2 (0.6) (0.3–2.6) |
One implant removed at the 5-year follow-up observation.
Participants having experienced post-operative biological and technical adverse events following the implant placement by time to event (pre-loading period–Loading–>Year 2–Year 2+)
| Control group (ITT = PP; | Experimental group (PP; | Originally allocated to experimental group, but intended intervention not received ( | |
|---|---|---|---|
| No adverse events whatsoever during first 5 years | 7 | 2 | 0 |
| Soft-tissue adverse events | |||
| Transient pain or Sensory disturbance | 0–1–2 | 0–0–1 | 0–0–0 |
| Transient swelling | 0–1–1 | 0–0–0 | 0–1–1 |
| Bleeding on probing | 0–0–7 | 0–0–4 | 0–0–2 |
| Implant system adverse events | |||
| Loosening of implant | 0–0–1 | 0–0–0 | 2–0–0 |
| FDP adverse events | |||
| Surface fractures (Most commonly tooth fractures) | 1–3–3 | 3–2–4 | 0–0–2 |
Sums exceed sample size because some participants experienced multiple different problems.
One participant accounted for seven soft-tissue adverse events.
Implant removed in 2012.
One participant accounted for eight fixed dental prosthesis (FDP) adverse events.
One participant accounted for six FDP adverse events.
Figure 8Representative fixed dental prostheses after 5 years.